
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The influence of the SARS-CoV-2 lockdown on patients with inflammatory rheumatic diseases on their adherence to immunomodulatory medication: a cross sectional study over 3 months in Germany
Rebecca Hasseli, Ulf Müller‐Ladner, Ferdinand Keil, et al.
Lara D. Veeken (2021) Vol. 60, Iss. SI, pp. SI51-SI58
Open Access | Times Cited: 12
Rebecca Hasseli, Ulf Müller‐Ladner, Ferdinand Keil, et al.
Lara D. Veeken (2021) Vol. 60, Iss. SI, pp. SI51-SI58
Open Access | Times Cited: 12
Showing 12 citing articles:
Impact of COVID-19 Pandemic on Adherence to Chronic Therapies: A Systematic Review
Elena Olmastroni, Federica Galimberti, Elena Tragni, et al.
International Journal of Environmental Research and Public Health (2023) Vol. 20, Iss. 5, pp. 3825-3825
Open Access | Times Cited: 33
Elena Olmastroni, Federica Galimberti, Elena Tragni, et al.
International Journal of Environmental Research and Public Health (2023) Vol. 20, Iss. 5, pp. 3825-3825
Open Access | Times Cited: 33
TNFi is associated with positive outcome, but JAKi and rituximab are associated with negative outcome of SARS-CoV-2 infection in patients with RMD
Anne C. Regierer, Rebecca Hasseli, Martin Schäfer, et al.
RMD Open (2021) Vol. 7, Iss. 3, pp. e001896-e001896
Open Access | Times Cited: 32
Anne C. Regierer, Rebecca Hasseli, Martin Schäfer, et al.
RMD Open (2021) Vol. 7, Iss. 3, pp. e001896-e001896
Open Access | Times Cited: 32
Influence of the COVID-19 Pandemic on Medical Management and on Healthcare Delivery of Immune-Mediated Rheumatic and Musculoskeletal Diseases during the First Pandemic Period February to July 2020: A Systematic Review
Marco Schlegel, Stefan Bachmann
Medicina (2024) Vol. 60, Iss. 4, pp. 596-596
Open Access | Times Cited: 3
Marco Schlegel, Stefan Bachmann
Medicina (2024) Vol. 60, Iss. 4, pp. 596-596
Open Access | Times Cited: 3
Increased Relapse Rate During COVID‐19 Lockdown in an Italian Cohort of Children With Juvenile Idiopathic Arthritis
Roberta Naddei, Renata Alfani, Martina Bove, et al.
Arthritis Care & Research (2021) Vol. 75, Iss. 2, pp. 326-331
Open Access | Times Cited: 14
Roberta Naddei, Renata Alfani, Martina Bove, et al.
Arthritis Care & Research (2021) Vol. 75, Iss. 2, pp. 326-331
Open Access | Times Cited: 14
Influence of the COVID-19 Pandemic on the Treatment of immune mediated Rheumatic and Musculoskeletal Diseases during the first pandemic period: A Systematic Review
Marco Schlegel, Stefan Bachmann
(2024)
Open Access | Times Cited: 1
Marco Schlegel, Stefan Bachmann
(2024)
Open Access | Times Cited: 1
Changes in treatment adherence and behaviour during the COVID-19 pandemic in Japanese patients with rheumatoid arthritis: Results from cross-sectional study in the IORRA cohort
Eiichi Tanaka, Eisuke Inoue, Mai Abe, et al.
Modern Rheumatology (2022) Vol. 32, Iss. 6, pp. 1193-1195
Open Access | Times Cited: 7
Eiichi Tanaka, Eisuke Inoue, Mai Abe, et al.
Modern Rheumatology (2022) Vol. 32, Iss. 6, pp. 1193-1195
Open Access | Times Cited: 7
Evaluation of a Non-Face-to-Face Multidisciplinary Health Care Model in a Population with Rheumatoid Arthritis Vulnerable to COVID-19 in a Health Emergency Situation
P. Santos-Moreno, G. S. Rodríguez-Vargas, Rosangela Casanova Libreros, et al.
Healthcare (2021) Vol. 9, Iss. 12, pp. 1744-1744
Open Access | Times Cited: 7
P. Santos-Moreno, G. S. Rodríguez-Vargas, Rosangela Casanova Libreros, et al.
Healthcare (2021) Vol. 9, Iss. 12, pp. 1744-1744
Open Access | Times Cited: 7
Impact of the First SARS-CoV-2 Lockdown on Adherence to Biological Treatment in Patients with Immune-Mediated Inflammatory Diseases in the Netherlands
Romy van der Groef, Pascal H P de Jong, DirkJan Hijnen, et al.
Patient Preference and Adherence (2023) Vol. Volume 17, pp. 167-174
Open Access | Times Cited: 1
Romy van der Groef, Pascal H P de Jong, DirkJan Hijnen, et al.
Patient Preference and Adherence (2023) Vol. Volume 17, pp. 167-174
Open Access | Times Cited: 1
Medication Adherence Evaluated Through Electronic Monitors During the 2020 COVID-19 Pandemic Lockdown in Switzerland: A Longitudinal Analysis
Carole Bandiera, Jérôme Pasquier, Isabella Locatelli, et al.
Patient Preference and Adherence (2022) Vol. Volume 16, pp. 2313-2320
Open Access | Times Cited: 2
Carole Bandiera, Jérôme Pasquier, Isabella Locatelli, et al.
Patient Preference and Adherence (2022) Vol. Volume 16, pp. 2313-2320
Open Access | Times Cited: 2
Deutsches Register www.Covid19-Rheuma.de
Rebecca Hasseli, Alexander Pfeil, Bimba F. Hoyer, et al.
Zeitschrift für Rheumatologie (2021) Vol. 80, Iss. 7, pp. 641-646
Open Access | Times Cited: 2
Rebecca Hasseli, Alexander Pfeil, Bimba F. Hoyer, et al.
Zeitschrift für Rheumatologie (2021) Vol. 80, Iss. 7, pp. 641-646
Open Access | Times Cited: 2
Microorganisms in the Pathogenesis and Management of Spondyloarthritis
Zhussipbek Mukhatayev, Aigul Sharip, Ayaulym Nurgozhina, et al.
(2022), pp. 419-458
Closed Access | Times Cited: 1
Zhussipbek Mukhatayev, Aigul Sharip, Ayaulym Nurgozhina, et al.
(2022), pp. 419-458
Closed Access | Times Cited: 1
COVID-19 und rheumatische Erkrankungen – bisherige Erkenntnisse der Pandemie
Rebecca Hasseli, Ulf Müller Ladner
DMW - Deutsche Medizinische Wochenschrift (2021) Vol. 146, Iss. 23, pp. 1564-1568
Closed Access | Times Cited: 1
Rebecca Hasseli, Ulf Müller Ladner
DMW - Deutsche Medizinische Wochenschrift (2021) Vol. 146, Iss. 23, pp. 1564-1568
Closed Access | Times Cited: 1